Tekla Capital Management LLC Exelixis, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 726,639 shares of EXEL stock, worth $24.2 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

726,639

Previous 726,639 -0.0%

Holding current value

$24.2 Million

Previous $14.1 Million 1.55%

% of portfolio

0.55%

Previous 0.54%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$16.3 - $19.41 $11.8 Million - $14.1 Million	726,639 New	726,639 $14.1 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $8.14 Million - $10.6 Million	-499,657 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $10.8 Million - $15.4 Million	-601,263 Reduced 54.61%	499,657 $9.1 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $3.19 Million - $3.92 Million	-155,600 Reduced 12.38%	1,100,920 $24.9 Million
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $2.97 Million - $4 Million	161,403 Added 14.74%	1,256,520 $25.2 Million
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $3.33 Million - $4.34 Million	161,168 Added 17.26%	1,095,117 $26.8 Million
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $6.89 Million - $11.5 Million	418,824 Added 81.31%	933,949 $22.2 Million
Q4 2019 Feb 13, 2020	BUY	$15.15 - $18.89 $2.78 Million - $3.46 Million	183,374 Added 55.27%	515,125 $9.08 Million
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $6.13 Million - $7.85 Million	-346,716 Reduced 51.1%	331,751 $5.87 Million
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $6.65 Million - $8.39 Million	339,032 Added 99.88%	678,467 $16.1 Million
Q4 2018 Feb 13, 2019	SELL	$13.65 - $21.8 $2.93 Million - $4.68 Million	-214,505 Reduced 38.72%	339,435 $6.68 Million
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $2 Million - $2.82 Million	125,918 Added 29.42%	553,940 $9.82 Million
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $727,552 - $880,040	39,200 Added 10.08%	428,022 $9.21 Million
Q3 2017 Nov 13, 2017	SELL	$23.35 - $29.24 $3.8 Million - $4.76 Million	-162,825 Reduced 29.52%	388,822 $9.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	551,647	551,647 $13.6 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Exelixis, Inc. Transaction History